The Gates Foundation will allocate up to $120 million to help lower-income countries get an experimental COVID-19 drug being developed by U.S. drugmaker Merck & Co Inc in the battle against coronavirus, it said on Wednesday.
The money will support efforts to develop and make generic versions of what could become the first oral antiviral medication for the disease if it wins regulatory approval, the foundation said in a statement.
"Today's commitment will ensure that more people in more countries get access to the promising drug molnupiravir, but it's not the end of the story - we need other donors, including foundations and governments, to act," Co-Chair Melinda French Gates said.
Merck is developing the antiviral pill along with partner Ridgeback Biotherapeutics, to treat coronavirus infections that range from mild to moderate in severity and sought U.S. emergency use authorisation for the drug this month.
The step comes as low- and middle-income countries struggle to secure life-saving vaccines and treatments for COVID-19, particularly in Africa, where just about 5% of the population is immunised.
On Tuesday, Reuters reported that an effort led by the World Health Organization to win fair access for poorer countries aims to get antiviral drugs for as little as $10 per course for people with mild symptoms.
Merck's drug is likely to be one of them.
Launched in 2000, the non-profit Bill & Melinda Gates Foundation is the United States' largest private philanthropic foundation and one of the world's biggest, pouring about $1.9 billion into the fight against the pandemic since last year.
More than 241.58 million people have been reported infected with the coronavirus worldwide, and more than 5.1 million have died, a Reuters tally shows.
Reuters
Wed Oct 20 2021
Launched in 2000, the non-profit Bill & Melinda Gates Foundation is the United States' largest private philanthropic foundation and one of the world's biggest, pouring about $1.9 billion into the fight against the pandemic since last year. - REUTERS
RM40 juta diluluskan di peringkat jawatankuasa MITRA, belum dibelanja - Prabakaran
Sebanyak RM40 juta daripada RM100 juta yang disalurkan kerajaan tahun ini kepada MITRA telah diluluskan di peringkat jawatankuasa.
Pengguna Facebook, Instagram luang 60% masa menonton video
Menurut Meta, kini pengguna meluangkan 60% daripada masa penggunaan di platform berkenaan dengan menonton video.
Rumah kebajikan warga emas dipukul tidak berdaftar - Nancy
Rumah kebajikan dihuni warga emas yang dipukul dengan kayu di Taman Desa Aman, Padang Serai, Kedah didapati tidak berdaftar dengan JKM.
Pasangan beregu badminton Soon Huat-Shevon kongsi gambar praperkahwinan
Pasangan beregu campuran negara, Goh Soon Huat-Shevon Lai, hari ini berkongsi gambar praperkahwinan mereka, yang dijangka akan dilangsungkan tidak lama lagi.
Kementerian Perpaduan lancar Inisiatif Harmoni Madani
Kementerian Perpaduan Negara hari ini melancarkan Inisiatif Harmoni Madani.
Kes 1MDB: Najib percaya Blackstone dikawal Arab Saudi, Raja Abdullah - Saksi
Saksi memberitahu Najib percaya bahawa syarikat Blackstone Asia Real Estate Partners dikawal oleh kerajaan Arab Saudi dan Raja Arab Saudi.
Apple dalam perbincangan guna teknologi OpenAI dalam iOS 18 - Laporan
iOS 18 akan membawakan perubahan paling besar untuk sistem operasi iPhone tahun ini dan integrasi sistem AI akan akhirnya didedahkan.
PRK Kuala Kubu Baharu: BN pamer komitmen tinggi pastikan kemenangan calon - Loke
BN menunjukkan komitmen tinggi dalam memastikan kemenangan calon PH, pada PRK Kuala Kubu Baharu.
Empat maut, dua pacuan empat roda bertembung
Empat individu maut dalam kemalangan melibatkan dua pacuan empat roda di Kilometer 78, Jalan Kota Bharu-Gua Musang tengah malam tadi.
Uqasha Senrose selamat bersalin, beri nama anak Uqaira
Pelakon Uqasha Senrose mengumumkan telah selamat melahirkan puteri sulungnya pada awal pagi Sabtu.
COVID-19: Merck mohon kelulusan kecemasan pil antiviral Molnupiravir
Ubat keluaran syarikat berkenaan bakal menjadi yang pertama digunakan untuk merawat pesakit COVID-19 jika diluluskan.